All Insights

Intellectual property

Podcast | The Future of FRAND

Following success in the UK Supreme Court earlier this year, Osborne Clarke’s Arty Rajendra discusses the impact of the judgment

Intellectual property

Unwired Planet unpacked: are English courts the de facto global tribunal for SEP licensing disputes?

Is the UK now effectively the forum for determining global FRAND licence terms, and, if so, is that a bad

Intellectual property

Advocate General casts doubt over hyperlink techniques

The opinion in a copyright case could have important implications for the use of inline framing and inline linking techniques

Intellectual property

Supreme Court Unwired Planet case unpacked: where will implementers turn next in FRAND disputes?

Landmark final appeal ruling means implementers of standards will now face the prospect of the English court setting worldwide licence

Life Sciences and Healthcare

A shot in the arm for generics as UK courts refuse injunction to prevent potential patent infringement

In an unusual decision for life sciences patent disputes, the UK courts refused to restrain a generic drug manufacturer from

Intellectual property

A unified patent court for Europe: the coup de grâce?

Will we ever see the Unified Patent Court operate? Many have doubts, as its path – already long and difficult

Life Sciences and Healthcare

UK Supreme Court upholds appeal by biotech firm Kymab to revoke antibody patents held by US giant Regeneron

Judgment overturns the Court of Appeal's decision on ground-breaking technology, rebalances the legal equilibrium on sufficiency, and grants reprieve to

Life Sciences and Healthcare

CJEU clarifies conditions for obtaining SPC protection for medicinal products

Royalty Pharma: the CJEU's latest decision on Supplementary Protection Certificates addresses when medicinal products can be "protected by a basic